Tissue Regenix eyes profits after revenues more than double in 2018
4th Feb 2019 11:52
(Sharecast News) - Medical devices company Tissue Regenix expects to breakeven in 2020 after seeing revenues more than double in its last trading year.
Read moreTissue Regenix CEO to take leave of absence due to ill health
6th Dec 2018 12:51
(Sharecast News) - The chief executive officer of Tissue Regenix, Steve Couldwell, will be taking a leave of absence from the start of the next year as he undergoes medical treatment.
Read moreTissue Regenix's losses widen as company pushes towards significant milestones
12th Oct 2016 14:03
(ShareCast News) - AIM-listed regenerative medical devices company Tissue Regenix Group's saw operating losses widen at the interim stage even as its revenues nudged higher, although it did gain regulatory approval for its products in Europe and the US. For the six months ended 31 July, revenue incr
Read moreTissue Regenix's devices a step closer to product launch
11th Jul 2016 15:58
(ShareCast News) - Regenerative medical device company Tissue Regenix released an update on two of its devices for a potential pilot study and product launch. The AIM listed company is currently undertaking clinical trials within the European Union for OrthoPure XT and OrthoPure XM products. The co
Read moreTissue Regenix announces German joint venture
26th Jan 2016 14:04
(ShareCast News) - Tissue Regenix announced its first step towards the commercialisation of two of its products on Tuesday, through a joint venture agreement with a German tissue bank. The AIM-listed company said it had entered into an agreement with GTM-V to form a venture called GBM-V, a tissue ba
Read moreTissue Regenix Group gains further Medicare approval for DermaPure
26th Jun 2015 08:47
Regenerative medical devices group Tissue Regenix has received approval for DermaPure(R) reimbursement from two further administrators of the Medicare health insurance programme in the US. The approval from the Noridian Healthcare Solutions and Palmetto GBA Medicare administrators means that DermaPu
Read moreTissue Regenix jumps as ACL treatment gets UK approval
28th Apr 2015 11:34
Shares in Tissue Regenix jumped on Tuesday, after the producer of devices for regenerative medicine said it had taken a "critical step" towards securing approval for a new treatment. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has given the green light to the first stage of c
Read moreTissue Regenix technology to be covered in European patent
25th Jul 2014 09:36
Tissue Regenix has received a decision to grant a European patent covering the use of its technology, strengthening its plan to issue a global roll-out of dCELL. The group's dCELL technology will be used in creating tissue implants for bladder repair. dCELL removes DNA material from animal and hu
Read moreTissue Regenix lauches DermaCare in US
12th Jun 2014 09:52
Tissue Regenix surged on Thursday after the launch of its skincare device DermaPure in the US following the signing of an exclusive government supplier partnership with TASSMA for the distribution of the treatment. The agreement will allow the firm to target the Department of Veteran's Affairs Heal
Read moreBroker tips: Carnival, SuperGroup, Tissue Regenix
12th Dec 2013 11:18
Numis Securities has kept its 'hold' rating and 2,250p target price for cruise operator Carnival ahead of its annual results next week, saying it may be too early for the firm to increase guidance. "The fourth quarter for Carnival is relatively small and seasonally weak and we do not expect any sur
Read moreBroker snap: Panmure raises bid hopes at Tissue Regenix
12th Dec 2013 10:54
Panmure Gordon has hiked its target price for AIM-listed medical devices company Tissue Regenix (TRX) by over a fifth after the signing of new sales distribution agreements in the US, highlighting the possibility that the firm could become a bid target in the future. The firm said on Thursday that
Read moreTissue Regenix perks up on US distribution deal
12th Dec 2013 08:44
AIM-listed Tissue Regenix has agreed seven sales distribution agreements in the US to promote its DermaPure human skin replacement device into hospitals. Shares in the company jumped over 16% to 20.13p as the company confirmed it was on course for 2014 commercial launch for its first product to be
Read moreThursday broker round-up UPDATE
12th Dec 2013 08:13
British American Tabacco: Credit Suisse reduces target price from 3700p to 3550p and retains its outperform rating. City of London Inc Group: N+1 Singer cuts target price from 260p to 220p downgrading to hold. Diageo: Credit Suisse reduces target price from 2350p to 2200p and maintains an outperfo
Read moreTissue Regenix H1 losses creep up as it ramps-up for US launch
8th Oct 2013 09:17
First half losses increased slightly at regenerative medicine specialist Tissue Regenix as it drove its products further towards commercialisation with several senior appointments made in the US. The pre-revenue company generated losses of £2.3m for the six months to July 31st that were in line wi
Read more